# EDGAR Filing Document

**Accession Number:** 0001867147
**File Stem:** 0001628280-25-044377
**Filing Date:** 2025-10
**Character Count:** 8175
**Document Hash:** 1cf757034caa262c851c751464a83260
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-044377.hdr.sgml**: 20251006

**ACCESSION NUMBER**: 0001628280-25-044377

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251002

**FILED AS OF DATE**: 20251006

**DATE AS OF CHANGE**: 20251006

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Scherman Jeffrey J
- **CENTRAL INDEX KEY:** 0001867147

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40537
- **FILM NUMBER:** 251377916

**MAIL ADDRESS:**
- **STREET 1:** C/O BRIGHT HEALTH GROUP, INC.
- **STREET 2:** 8000 NORMAN CENTER DRIVE, SUITE 1200
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55437
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NeueHealth, Inc.
- **CENTRAL INDEX KEY:** 0001671284
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 474991296
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9250 NW 36TH STREET
- **STREET 2:** SUITE 420
- **CITY:** DORAL
- **STATE:** FL
- **ZIP:** 33178
- **BUSINESS PHONE:** 612-238-1321

**MAIL ADDRESS:**
- **STREET 1:** 9250 NW 36TH STREET
- **STREET 2:** SUITE 420
- **CITY:** DORAL
- **STATE:** FL
- **ZIP:** 33178

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bright Health Group Inc.
- **DATE OF NAME CHANGE:** 20210309

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bright Health Inc.
- **DATE OF NAME CHANGE:** 20160404

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Scherman Jeffrey J<br><sub>(Last) (First) (Middle)</sub><br>C/O NEUEHEALTH, INC.<br>9250 NW 36TH ST SUITE 420<br><sub>(Street)</sub><br>DORAL, FL 33178<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Accounting Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>NeueHealth, Inc. [ NEUE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-10-02 |  | D<sup>(1)</sup> |  | 12463 | D | 7.33<sup>(2)</sup> | 0 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(3)</sup> | 2025-10-02 |  | D<sup>(1)</sup> |  |  | 11000 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 11000 | <sup>(5)</sup> | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-10-02 |  | D<sup>(1)</sup> |  |  | 50000 | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 50000 | <sup>(5)</sup> | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-10-02 |  | D<sup>(1)</sup> |  |  | 2490 | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 2490 | <sup>(5)</sup> | 0 | D |  |

---

### Footnotes:

(1) On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.

(2) At the effective time of the Merger ("Effective Time"), each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $7.33 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

(3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

(4) The original grant of these restricted stock units vest in equal annual installments beginning on 3/11/24.

(5) Each Issuer restricted stock unit ("RSU") outstanding immediately prior to the Effective Time was assumed and adjusted into a restricted stock unit with respect to a number of shares of common stock of Parent equal to the number of shares of Issuer common stock subject to such Issuer RSU and continued to be subject to the same terms and restrictions set forth in the Issuer equity plans and any applicable individual award agreement issued thereunder (including with respect to vesting).

(6) All of these restricted stock units vest on 10/11/26.

(7) The original grant of these restricted stock units vest in equal annual installments beginning on 3/6/23.

**Signature:** /s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact  
**Date:** 2025-10-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**